Same Indication

Nivolumab vs Sildenafil

Nivolumab vs Sildenafil: Overview

This comparison examines the pharmacological differences between Nivolumab and Sildenafil.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Sildenafil: Selective PDE5 inhibitor increasing cGMP.

Pharmacokinetics

Half-life: Nivolumab — 27 days; Sildenafil — 4 hours.

Chemical Properties

Molecular Formula: Sildenafil — C22H30N6O4S.

Molecular Weight: Sildenafil — 474.5800 g/mol.

Type: Nivolumab — Antibody; Sildenafil — Small molecule.